ArticleThe British journal of radiology2024

Cyclin-dependent kinase 4/6 inhibitors combined with stereotactic ablative radiotherapy in oligometastatic HR-positive/HER2-negative breast cancer patients.

Marcin Kubeczko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.